http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Wed, 05 Aug 2026 17:01:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++STANDARD+BIOTOOLS+INC.+++++++++++++++/26875631.html si-local-file:///var/storage/secattach/20260805/26875631.html http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++STANDARD+BIOTOOLS+INC.+++++++++++++++/26875631.html Wed, 05 Aug 2026 17:01:00 -0400 LAB O.00073707 http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++STANDARD+BIOTOOLS+INC.+++++++++++++++/26875631.html si-local-file:///var/storage/secattach/20260805/26875631.html http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++STANDARD+BIOTOOLS+INC.+++++++++++++++/26875631.html Wed, 05 Aug 2026 17:01:00 -0400 LAB O.00073707 http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++STANDARD+BIOTOOLS+INC.+++++++++++++++/26875622.html si-local-file:///var/storage/secattach/20260805/26875622.html http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++STANDARD+BIOTOOLS+INC.+++++++++++++++/26875622.html Wed, 05 Aug 2026 17:00:00 -0400 LAB O.00073707 http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++STANDARD+BIOTOOLS+INC.+++++++++++++++/26875622.html si-local-file:///var/storage/secattach/20260805/26875622.html http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++STANDARD+BIOTOOLS+INC.+++++++++++++++/26875622.html Wed, 05 Aug 2026 17:00:00 -0400 LAB O.00073707 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++STANDARD+BIOTOOLS+INC.++++For%3A+Aug+05/26874280.html si-local-file:///var/storage/secattach/20260805/26874280.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++STANDARD+BIOTOOLS+INC.++++For%3A+Aug+05/26874280.html Wed, 05 Aug 2026 16:11:00 -0400 LAB O.00073707 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++STANDARD+BIOTOOLS+INC.++++For%3A+Aug+05/26874280.html si-local-file:///var/storage/secattach/20260805/26874280.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++STANDARD+BIOTOOLS+INC.++++For%3A+Aug+05/26874280.html Wed, 05 Aug 2026 16:11:00 -0400 LAB O.00073707 http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++STANDARD+BIOTOOLS+INC.++++For%3A+Jun+30/26874412.html si-local-file:///var/storage/secattach/20260805/26874412.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++STANDARD+BIOTOOLS+INC.++++For%3A+Jun+30/26874412.html Wed, 05 Aug 2026 16:11:00 -0400 LAB O.00073707 http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++STANDARD+BIOTOOLS+INC.++++For%3A+Jun+30/26874412.html si-local-file:///var/storage/secattach/20260805/26874412.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++STANDARD+BIOTOOLS+INC.++++For%3A+Jun+30/26874412.html Wed, 05 Aug 2026 16:11:00 -0400 LAB O.00073707 http://www.streetinsider.com/Press+Releases/Standard+BioTools+Reports+Second+Quarter+2026+Financial+Results/26873849.html <p>BOSTON, Mass., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) (the “Company” or “Standard BioTools”) today announced financial results for the quarter ended June 30, 2026.</p> <p><strong>Recent Highlights:</strong></p> <ul type="disc"><li style="margin-bottom:6pt;"><em>Second quarter 2026 revenue of $20.1 million</em></li><li style="margin-bottom:6pt;"><em>1% improvement in operating loss and 84% improvement in adjusted EBITDA year-over-year</em></li><li style="margin-bottom:6pt;"><em>Merger with Treeline Biosciences progressing toward stockholder vote and anticipated to close before year-end 2026</em><br/></li></ul> <p>“We remain on track to close our merger with Treeline Biosciences in 2026, with our previously filed registration statement on Form S-4, our agreement to divest our Mass http://www.streetinsider.com/Press+Releases/Standard+BioTools+Reports+Second+Quarter+2026+Financial+Results/26873849.html Wed, 05 Aug 2026 16:05:00 -0400 A.50216938 LAB O.00073707 O.61332621 http://www.streetinsider.com/Press+Releases/Standard+BioTools+Reports+Second+Quarter+2026+Financial+Results/26873849.html <p>BOSTON, Mass., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) (the “Company” or “Standard BioTools”) today announced financial results for the quarter ended June 30, 2026.</p> <p><strong>Recent Highlights:</strong></p> <ul type="disc"><li style="margin-bottom:6pt;"><em>Second quarter 2026 revenue of $20.1 million</em></li><li style="margin-bottom:6pt;"><em>1% improvement in operating loss and 84% improvement in adjusted EBITDA year-over-year</em></li><li style="margin-bottom:6pt;"><em>Merger with Treeline Biosciences progressing toward stockholder vote and anticipated to close before year-end 2026</em><br/></li></ul> <p>“We remain on track to close our merger with Treeline Biosciences in 2026, with our previously filed registration statement on Form S-4, our agreement to divest our Mass http://www.streetinsider.com/Press+Releases/Standard+BioTools+Reports+Second+Quarter+2026+Financial+Results/26873849.html Wed, 05 Aug 2026 16:05:00 -0400 A.50216938 LAB O.00073707 O.61332621 http://www.streetinsider.com/Press+Releases/Standard+BioTools+Reports+Second+Quarter+2026+Financial+Results/26873849.html <p>BOSTON, Mass., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) (the “Company” or “Standard BioTools”) today announced financial results for the quarter ended June 30, 2026.</p> <p><strong>Recent Highlights:</strong></p> <ul type="disc"><li style="margin-bottom:6pt;"><em>Second quarter 2026 revenue of $20.1 million</em></li><li style="margin-bottom:6pt;"><em>1% improvement in operating loss and 84% improvement in adjusted EBITDA year-over-year</em></li><li style="margin-bottom:6pt;"><em>Merger with Treeline Biosciences progressing toward stockholder vote and anticipated to close before year-end 2026</em><br/></li></ul> <p>“We remain on track to close our merger with Treeline Biosciences in 2026, with our previously filed registration statement on Form S-4, our agreement to divest our Mass http://www.streetinsider.com/Press+Releases/Standard+BioTools+Reports+Second+Quarter+2026+Financial+Results/26873849.html Wed, 05 Aug 2026 16:05:00 -0400 A.50216938 LAB O.00073707 O.61332621 http://www.streetinsider.com/Press+Releases/Standard+BioTools+Reports+Second+Quarter+2026+Financial+Results/26873849.html <p>BOSTON, Mass., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) (the “Company” or “Standard BioTools”) today announced financial results for the quarter ended June 30, 2026.</p> <p><strong>Recent Highlights:</strong></p> <ul type="disc"><li style="margin-bottom:6pt;"><em>Second quarter 2026 revenue of $20.1 million</em></li><li style="margin-bottom:6pt;"><em>1% improvement in operating loss and 84% improvement in adjusted EBITDA year-over-year</em></li><li style="margin-bottom:6pt;"><em>Merger with Treeline Biosciences progressing toward stockholder vote and anticipated to close before year-end 2026</em><br/></li></ul> <p>“We remain on track to close our merger with Treeline Biosciences in 2026, with our previously filed registration statement on Form S-4, our agreement to divest our Mass http://www.streetinsider.com/Press+Releases/Standard+BioTools+Reports+Second+Quarter+2026+Financial+Results/26873849.html Wed, 05 Aug 2026 16:05:00 -0400 A.50216938 LAB O.00073707 O.61332621 http://www.streetinsider.com/Globe+Newswire/Standard+BioTools+Reports+Second+Quarter+2026+Financial+Results/26873849.html <p>BOSTON, Mass., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) (the “Company” or “Standard BioTools”) today announced financial results for the quarter ended June 30, 2026.</p> <p><strong>Recent Highlights:</strong></p> <ul type="disc"><li style="margin-bottom:6pt;"><em>Second quarter 2026 revenue of $20.1 million</em></li><li style="margin-bottom:6pt;"><em>1% improvement in operating loss and 84% improvement in adjusted EBITDA year-over-year</em></li><li style="margin-bottom:6pt;"><em>Merger with Treeline Biosciences progressing toward stockholder vote and anticipated to close before year-end 2026</em><br/></li></ul> <p>“We remain on track to close our merger with Treeline Biosciences in 2026, with our previously filed registration statement on Form S-4, our agreement to divest our Mass http://www.streetinsider.com/Globe+Newswire/Standard+BioTools+Reports+Second+Quarter+2026+Financial+Results/26873849.html Wed, 05 Aug 2026 16:05:00 -0400 A.50216938 LAB O.00073707 O.61332621 http://www.streetinsider.com/Globe+Newswire/Standard+BioTools+Reports+Second+Quarter+2026+Financial+Results/26873849.html <p>BOSTON, Mass., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) (the “Company” or “Standard BioTools”) today announced financial results for the quarter ended June 30, 2026.</p> <p><strong>Recent Highlights:</strong></p> <ul type="disc"><li style="margin-bottom:6pt;"><em>Second quarter 2026 revenue of $20.1 million</em></li><li style="margin-bottom:6pt;"><em>1% improvement in operating loss and 84% improvement in adjusted EBITDA year-over-year</em></li><li style="margin-bottom:6pt;"><em>Merger with Treeline Biosciences progressing toward stockholder vote and anticipated to close before year-end 2026</em><br/></li></ul> <p>“We remain on track to close our merger with Treeline Biosciences in 2026, with our previously filed registration statement on Form S-4, our agreement to divest our Mass http://www.streetinsider.com/Globe+Newswire/Standard+BioTools+Reports+Second+Quarter+2026+Financial+Results/26873849.html Wed, 05 Aug 2026 16:05:00 -0400 A.50216938 LAB O.00073707 O.61332621 http://www.streetinsider.com/Globe+Newswire/Standard+BioTools+Reports+Second+Quarter+2026+Financial+Results/26873849.html <p>BOSTON, Mass., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) (the “Company” or “Standard BioTools”) today announced financial results for the quarter ended June 30, 2026.</p> <p><strong>Recent Highlights:</strong></p> <ul type="disc"><li style="margin-bottom:6pt;"><em>Second quarter 2026 revenue of $20.1 million</em></li><li style="margin-bottom:6pt;"><em>1% improvement in operating loss and 84% improvement in adjusted EBITDA year-over-year</em></li><li style="margin-bottom:6pt;"><em>Merger with Treeline Biosciences progressing toward stockholder vote and anticipated to close before year-end 2026</em><br/></li></ul> <p>“We remain on track to close our merger with Treeline Biosciences in 2026, with our previously filed registration statement on Form S-4, our agreement to divest our Mass http://www.streetinsider.com/Globe+Newswire/Standard+BioTools+Reports+Second+Quarter+2026+Financial+Results/26873849.html Wed, 05 Aug 2026 16:05:00 -0400 A.50216938 LAB O.00073707 O.61332621 http://www.streetinsider.com/Globe+Newswire/Standard+BioTools+Reports+Second+Quarter+2026+Financial+Results/26873849.html <p>BOSTON, Mass., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) (the “Company” or “Standard BioTools”) today announced financial results for the quarter ended June 30, 2026.</p> <p><strong>Recent Highlights:</strong></p> <ul type="disc"><li style="margin-bottom:6pt;"><em>Second quarter 2026 revenue of $20.1 million</em></li><li style="margin-bottom:6pt;"><em>1% improvement in operating loss and 84% improvement in adjusted EBITDA year-over-year</em></li><li style="margin-bottom:6pt;"><em>Merger with Treeline Biosciences progressing toward stockholder vote and anticipated to close before year-end 2026</em><br/></li></ul> <p>“We remain on track to close our merger with Treeline Biosciences in 2026, with our previously filed registration statement on Form S-4, our agreement to divest our Mass http://www.streetinsider.com/Globe+Newswire/Standard+BioTools+Reports+Second+Quarter+2026+Financial+Results/26873849.html Wed, 05 Aug 2026 16:05:00 -0400 A.50216938 LAB O.00073707 O.61332621 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++STANDARD+BIOTOOLS+INC.++++For%3A+Aug+03++Filed+by%3A+Egholm+Michael/26868304.html si-local-file:///var/storage/secattach/20260804/26868304.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++STANDARD+BIOTOOLS+INC.++++For%3A+Aug+03++Filed+by%3A+Egholm+Michael/26868304.html Tue, 04 Aug 2026 18:01:00 -0400 LAB O.00073707 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++STANDARD+BIOTOOLS+INC.++++For%3A+Aug+03++Filed+by%3A+Egholm+Michael/26868304.html si-local-file:///var/storage/secattach/20260804/26868304.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++STANDARD+BIOTOOLS+INC.++++For%3A+Aug+03++Filed+by%3A+Egholm+Michael/26868304.html Tue, 04 Aug 2026 18:01:00 -0400 LAB O.00073707 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++STANDARD+BIOTOOLS+INC.+++++++++++++++++Filed+by%3A+BlackRock%2C+Inc./26841272.html si-local-file:///var/storage/secattach/20260730/26841272.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++STANDARD+BIOTOOLS+INC.+++++++++++++++++Filed+by%3A+BlackRock%2C+Inc./26841272.html Thu, 30 Jul 2026 11:19:00 -0400 LAB O.00073707 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++STANDARD+BIOTOOLS+INC.+++++++++++++++++Filed+by%3A+BlackRock%2C+Inc./26841272.html si-local-file:///var/storage/secattach/20260730/26841272.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++STANDARD+BIOTOOLS+INC.+++++++++++++++++Filed+by%3A+BlackRock%2C+Inc./26841272.html Thu, 30 Jul 2026 11:19:00 -0400 LAB O.00073707 http://www.streetinsider.com/SEC+Filings/Form++8-KA++++++STANDARD+BIOTOOLS+INC.++++For%3A+Jul+28/26831069.html si-local-file:///var/storage/secattach/20260729/26831069.html http://www.streetinsider.com/SEC+Filings/Form++8-KA++++++STANDARD+BIOTOOLS+INC.++++For%3A+Jul+28/26831069.html Wed, 29 Jul 2026 08:16:00 -0400 LAB O.00073707 http://www.streetinsider.com/SEC+Filings/Form++8-KA++++++STANDARD+BIOTOOLS+INC.++++For%3A+Jul+28/26831069.html si-local-file:///var/storage/secattach/20260729/26831069.html http://www.streetinsider.com/SEC+Filings/Form++8-KA++++++STANDARD+BIOTOOLS+INC.++++For%3A+Jul+28/26831069.html Wed, 29 Jul 2026 08:16:00 -0400 LAB O.00073707 http://www.streetinsider.com/SEC+Filings/Form++425++++++++STANDARD+BIOTOOLS+INC.+++++++++++++++++Filed+by%3A+STANDARD+BIOTOOLS+INC./26831072.html si-local-file:///var/storage/secattach/20260729/26831072.html http://www.streetinsider.com/SEC+Filings/Form++425++++++++STANDARD+BIOTOOLS+INC.+++++++++++++++++Filed+by%3A+STANDARD+BIOTOOLS+INC./26831072.html Wed, 29 Jul 2026 08:16:00 -0400 LAB O.00073707 http://www.streetinsider.com/SEC+Filings/Form++425++++++++STANDARD+BIOTOOLS+INC.+++++++++++++++++Filed+by%3A+STANDARD+BIOTOOLS+INC./26831072.html si-local-file:///var/storage/secattach/20260729/26831072.html http://www.streetinsider.com/SEC+Filings/Form++425++++++++STANDARD+BIOTOOLS+INC.+++++++++++++++++Filed+by%3A+STANDARD+BIOTOOLS+INC./26831072.html Wed, 29 Jul 2026 08:16:00 -0400 LAB O.00073707 http://www.streetinsider.com/SEC+Filings/Form++425++++++++STANDARD+BIOTOOLS+INC.+++++++++++++++++Filed+by%3A+STANDARD+BIOTOOLS+INC./26823125.html si-local-file:///var/storage/secattach/20260728/26823125.html http://www.streetinsider.com/SEC+Filings/Form++425++++++++STANDARD+BIOTOOLS+INC.+++++++++++++++++Filed+by%3A+STANDARD+BIOTOOLS+INC./26823125.html Tue, 28 Jul 2026 08:36:00 -0400 LAB O.00073707